I wrote something a while ago. please read through my previous post a couple months ago.
in short - Ph2 is toughest because most jump from animal to human models. BOT has already de-risked this transition by conducting preclinical studies in humans. combine that with the fact it's also a topical administration and in the derma field. risk still remains mind you, but it's significantly de-risked IMO. they've done this for a reason, spending on phase 1b trials to test in a human cohort was a very wise move.
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-2141
-
- There are more pages in this discussion • 12,079 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
37.0¢ | 38.0¢ | 36.5¢ | $734.5K | 1.972M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 324837 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 126434 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 324837 | 0.370 |
9 | 272064 | 0.365 |
10 | 502187 | 0.360 |
8 | 167011 | 0.355 |
8 | 518350 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 126434 | 2 |
0.380 | 934757 | 19 |
0.385 | 238502 | 8 |
0.390 | 373662 | 21 |
0.395 | 378120 | 10 |
Last trade - 13.18pm 15/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online